"Third time lucky as PharmaTher gets FDA approval for ketamine" was originally created and published by Pharmaceutical ...

A new Wisconsin law will to ban non-FDA approved vape products will go into effect on September 1st of Labor Day Weekend.

The condition MASH (Metabolic Dysfunction-Associated Steatohepatitis) is common and serious.

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...

Wegovy is now the second medicine approved in the U.S. for a disease that affects millions. Novo Nordisk has several other factors working in its favor, including strong results and a solid pipeline.

For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration (FDA) has ...

The U.S. Food and Drug Administration on Thursday approved Ionis Pharmaceuticals' drug to prevent instances of severe ...

Insmed's Brinsupri is the first DPP1 inhibitor approved by the FDA and the first treatment for bronchiectasis to reach the ...

Developed by Ionis Pharmaceuticals, Dawnzera is the first RNA-targeted medicine approved for HAE, designed to target plasma ...